Instalab

B. Quintana Antibody IgM Screen

Test
Catch a recent or active trench fever infection before it settles into your heart or blood vessels.

Should you take a B. Quintana Antibody IgM Screen test?

This test is most useful if any of these apply to you.

Dealing With Unexplained Fevers
If you have persistent fever with no clear cause and normal routine labs, this test can flag an infection that standard panels miss.
Investigating a Heart Murmur
A new murmur with fatigue or weight loss can signal valve infection, and this test catches a bacterial cause that blood cultures often cannot grow.
Living With a Mysterious Rash
Recurrent or vasculitic skin rashes paired with fevers can point to an infection that this antibody can help identify early.
Exposed to Body Lice or Stray Cats
Body lice and stray cat contact are the main routes of transmission, and this test can confirm whether exposure has turned into infection.

About B. Quintana Antibody IgM Screen

Bartonella quintana is the bacterium behind trench fever, an infection most famous from the trenches of World War I but still circulating today, especially among people exposed to body lice, unstable housing, or close contact with stray cats. When your body first encounters it, the immune system pumps out an early-response antibody called IgM, which can show up in your blood within days to weeks of infection.

A positive B. quintana IgM (Bartonella quintana immunoglobulin M) result can flag a recent or active infection that standard blood cultures often miss, since this organism is notoriously hard to grow in the lab. A negative result is not a clean bill of health, but in the right clinical setting, a positive IgM combined with symptoms is one of the earliest signs that something serious may be brewing.

What This Antibody Actually Reflects

IgM is the first class of antibody your immune system makes when it sees a new threat. For B. quintana, IgM typically rises in the acute phase of infection and then declines over weeks as your body shifts production to IgG (immunoglobulin G), a longer-lasting antibody that signals ongoing or past exposure. A documented case showed exactly this pattern: B. quintana IgM at a titer of 1:256 with undetectable IgG during acute illness, then five weeks later IgM was gone and IgG appeared at 1:64.

This is why IgM is treated as a marker of recent or active disease, while IgG points more toward past or chronic exposure. The two together tell a story about where you are in the infection.

Heart Infection Risk (Endocarditis)

The most serious thing B. quintana can do to you is cause endocarditis, an infection of the heart valves that often grows quietly over months. It is one of the leading culprits behind blood culture-negative endocarditis, meaning standard cultures come back clean even though infection is destroying valve tissue.

Here is the catch: by the time endocarditis is established, IgM is usually gone. In an Iranian series of 50 surgical patients with blood culture-negative endocarditis, every single patient tested negative for Bartonella IgM, even the one with PCR-confirmed B. quintana on the valve. That patient had high IgG instead. So IgM is most useful early, before chronic infection sets in, and a negative IgM in someone with a longstanding heart murmur does not rule out the disease.

Reconciling the Acute vs Chronic Picture

It can feel contradictory that a single biomarker is helpful in some B. quintana infections and useless in others. The resolution is timing. IgM is an acute-phase signal. It catches the early window of infection but disappears as the immune response matures. In long-standing infections like valve endocarditis, the body has already finished its IgM phase and switched to IgG. IgM negative does not mean infection negative; it means whatever is happening is either recent (and IgM has not yet appeared), already chronic (and IgM has faded), or not B. quintana at all. Reading IgM correctly requires knowing roughly how long symptoms have been present.

Skin and Blood Vessel Inflammation

B. quintana can also show up as a vasculitic rash, where small blood vessels in the skin become inflamed. A documented acute infection with a leucocytoclastic vasculitis rash was caught with a positive B. quintana IgM (1:256) while IgG was still negative. After two weeks of doxycycline, the fever broke within 36 hours and the patient fully recovered. This is one of the situations where catching IgM early can directly change the course of illness.

Bacteremia and Persistent Fever

B. quintana can also cause bacteremia, meaning live bacteria circulating in the bloodstream, often presenting as unexplained fever that comes and goes. In a study of 1,922 patients with persistent febrile illness across Cambodia, Nepal, Sudan, and the Democratic Republic of Congo, 16.6% of cases were tied to either Coxiella burnetii or Bartonella species infections. This is a meaningful slice of fever cases that get missed when only routine workups are done.

Why a Single Reading Can Fool You

Bartonella serology has known weaknesses, and one IgM reading taken in isolation can mislead in several ways. The most important issues come from how the test cross-reacts and from the natural timing of antibody production.

  • Cross-reactivity with related bacteria: Bartonella tests can react with antibodies against B. henselae (the cat-scratch disease organism), Coxiella burnetii, Chlamydia species, and others, making it hard to know exactly which species is responsible.
  • False negatives in chronic infection: In long-standing B. quintana endocarditis, IgM is often absent even when valve tissue PCR proves active infection.
  • Timing mismatch: Testing too early in the infection (before IgM rises) or too late (after it has faded) can produce a negative result in someone who is genuinely infected.
  • Background seropositivity: Healthy populations can carry low-level antibodies from past exposure. Some seroprevalence studies have reported that a meaningful share of healthy blood donors test positive for Bartonella antibodies, with poor correlation to active infection.

Tracking Your Trend

A single antibody titer is a snapshot, not a story. The most reliable serologic evidence of active infection is a four-fold rise in titer between an acute sample and one drawn two to four weeks later, or a clear shift from IgM-positive/IgG-negative to IgM-negative/IgG-positive over weeks. If you have an initial positive IgM, retesting in 2 to 6 weeks helps confirm whether your immune system is responding to a real infection or whether the first reading was background noise or cross-reactivity.

If symptoms are ongoing and your first IgM was negative, a repeat test in 1 to 2 weeks may catch the antibody rise that had not yet happened. Serial testing matters here far more than any single number.

Decision Pathway for an Unexpected Result

If your B. quintana IgM comes back positive, do not stop with one test. The next steps depend on your symptoms and risk factors:

  • Confirm with IgG and PCR: Ask for a paired B. quintana IgG and, where available, a PCR (polymerase chain reaction) test that detects bacterial DNA directly. PCR targeting the ssrA gene has excellent sensitivity and specificity for Bartonella, especially when serology is ambiguous.
  • Get an echocardiogram if heart symptoms are present: Unexplained fevers with a new murmur, fatigue, or weight loss warrant a transesophageal echocardiogram to look for valve vegetations, since B. quintana endocarditis often grows silently for months.
  • Loop in an infectious disease specialist: Bartonella is a niche infection, and treatment regimens (often doxycycline plus an aminoglycoside or rifampin for endocarditis) are best guided by someone who sees these cases.
  • Investigate exposure history: Body lice contact, homelessness, prolonged outdoor exposure, or close contact with stray cats all raise the pretest probability and change how aggressively to pursue confirmation.

A negative IgM in someone with high clinical suspicion is not a stopping point either. If symptoms persist, push for IgG testing, PCR on blood or biopsied tissue, and specialist input. The combination of clinical picture, multiple antibody classes, and molecular testing carries far more weight than any single result.

What Moves This Biomarker

Evidence-backed interventions that affect your B. Quintana Antibody IgM Screen level

Decrease
Doxycycline antibiotic therapy for acute B. quintana infection
Treating an active B. quintana infection clears the bacteria and shifts your antibody profile. In a documented acute case treated with doxycycline 100 mg twice daily for 14 days, fever resolved within 36 hours, and follow-up serology five weeks later showed IgM had dropped from 1:256 to undetectable while IgG appeared at 1:64. This is the expected acute-to-convalescent shift after successful treatment.
MedicationStrong Evidence
Increase
Exposure to body lice or unstable housing conditions
Body lice are the primary vector for B. quintana, and prolonged exposure substantially raises the likelihood of infection and a detectable antibody response. Among people experiencing homelessness in Denver, B. quintana was identified as a serious and underrecognized cause of infection, with ongoing transmission documented in this population.
LifestyleStrong Evidence
Increase
Close contact with stray or feral cats
Contact with stray cats has been linked to B. quintana infection, including a documented case of blood culture-negative endocarditis in a patient whose only identifiable exposure was contact with stray cats. Increased exposure raises the chance of infection and a measurable antibody response.
LifestyleModerate Evidence

Frequently Asked Questions

Panels containing B. Quintana Antibody IgM Screen

B. Quintana Antibody IgM Screen is included in these pre-built panels.

References

19 studies
  1. Azimzadeh M, Alikhani MY, Sazmand a, Saberi K, Farahani Z, Kamali M, Haddadzadeh M, Safarpoor G, Nourian a, Mohammadi Y, Beikpour F, Salehi M, Greco G, Chomel BScientific Reports2024
  2. Hopkins BJ, Prokesch BCOpen Forum Infectious Diseases2021
  3. Rothova a, Kerkhoff F, Hooft HJ, Ossewaarde JRetina1998
  4. Kim L, Lashnits EW, Breitschwerdt E, Elam a, Grade N, Miller JC, Shikhman ARMicrobiology Spectrum2024
  5. Pape M, Mandraveli K, Alexiou-daniel SClinical Microbiology and Infection2009